- Home
- KEYS vs BNTX Comparison
KEYS vs BNTX Comparison
Compare KEYS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEYS
- BNTX
- Stock Information
- Founded
- KEYS 1939
- BNTX 2008
- Country
- KEYS United States
- BNTX Germany
- Employees
- KEYS N/A
- BNTX N/A
- Industry
- KEYS Industrial Machinery/Components
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KEYS Industrials
- BNTX Health Care
- Exchange
- KEYS Nasdaq
- BNTX Nasdaq
- Market Cap
- KEYS 28.6B
- BNTX 26.4B
- IPO Year
- KEYS N/A
- BNTX 2019
- Fundamental
- Price
- KEYS $170.61
- BNTX $96.74
- Analyst Decision
- KEYS Buy
- BNTX Strong Buy
- Analyst Count
- KEYS 8
- BNTX 18
- Target Price
- KEYS $187.38
- BNTX $139.49
- AVG Volume (30 Days)
- KEYS 1.1M
- BNTX 1.1M
- Earning Date
- KEYS 08-19-2025
- BNTX 11-03-2025
- Dividend Yield
- KEYS N/A
- BNTX N/A
- EPS Growth
- KEYS N/A
- BNTX N/A
- EPS
- KEYS 3.14
- BNTX N/A
- Revenue
- KEYS $5,243,000,000.00
- BNTX $3,380,387,551.00
- Revenue This Year
- KEYS $9.24
- BNTX N/A
- Revenue Next Year
- KEYS $6.38
- BNTX $15.19
- P/E Ratio
- KEYS $54.38
- BNTX N/A
- Revenue Growth
- KEYS 4.80
- BNTX 6.98
- 52 Week Low
- KEYS $121.43
- BNTX $81.20
- 52 Week High
- KEYS $186.20
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- KEYS 59.09
- BNTX 37.48
- Support Level
- KEYS $159.82
- BNTX $99.90
- Resistance Level
- KEYS $172.99
- BNTX $104.48
- Average True Range (ATR)
- KEYS 2.65
- BNTX 4.24
- MACD
- KEYS 0.67
- BNTX -0.47
- Stochastic Oscillator
- KEYS 81.92
- BNTX 26.73
About KEYS Keysight Technologies Inc.
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.